In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Biree Andemariam, MD
Professor of Medicine
Division of Hematology/Oncology
Director, New England Sickle Cell Institute
Director, Connecticut Bleeding Disorders Center
University of Connecticut Health
Farmington, CT
Consulting Fees: Accordant, Afimmune, Agios, Bluebird Bio, Emmaus, Forma Therapeutics, GlaxoSmithKline, Global Blood Therapeutics, Hemanext, Novartis, NovoNordisk, Sanofi Genzyme, Vertex
Research: American Society of Hematology, Connecticut Department of Public Health, Forma Therapeutics, Global Blood Therapeutics, Hemanext, HRSA, Novartis, PCORI
Faculty:
Caroline E. Freiermuth, MD
Associate Professor of Emergency Medicine
University of Cincinnati
Cincinnati, OH
Consulting Fees: CSL Behring
Reviewers/Content Planners/Authors:
- Jennifer Brutsche has nothing to disclose.
- Cindy Davidson has nothing to disclose.
- Barry Fiedel has nothing to disclose.
- Keith Johnson has nothing to disclose.
- Tim Person has nothing to disclose.
- Mara Siegel has nothing to disclose.
Facebook Comments